LNPs vs. Conventional Liposomes: A Short Review Of Core Structural And Manufacturing Differences

An interview with Jay Natarajan, Ph.D., Director R&D, Evonik Health Care

Those who think that liposomes and lipid nanoparticles (LNPs) are interchangeable terms for the same drug delivery technology would be wrong. Key differences exist not only in their target applications, but their actual morphology, composition and manufacturing process. In this interview with Dr. Jay Natarajan, one of Evonik’s formulation and manufacturing experts for LNPs and liposomes, some of these differences are reviewed.